| Dr William S Sarnat, MD | |
|
611 E Douglas Rd, Ste 208, Mishawaka, IN 46545-1464 | |
| (574) 232-5928 | |
| (574) 232-4888 |
| Full Name | Dr William S Sarnat |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 611 E Douglas Rd, Mishawaka, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346244746 | NPI | - | NPPES |
| 100145470 | Medicaid | IN | |
| 100145470A | Medicaid | IN | |
| 000000805942 | Other | IN | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01027609 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William S Sarnat, MD Po Box 6309, South Bend, IN 46660-6309 Ph: (574) 335-8600 | Dr William S Sarnat, MD 611 E Douglas Rd, Ste 208, Mishawaka, IN 46545-1464 Ph: (574) 232-5928 |
News Archive
During a Senate Finance Committee hearing, an administration official said the potential of the these efforts to show cost-lowering results would take time.
The National Institutes of Health (NIH) has awarded a five-year, $9 million grant to the University of Houston's Texas Center for Learning Disabilities to conduct research on the causes and treatment of learning disabilities in children and adolescents. UH is one of four universities nationally to receive funding from the NIH for a learning disability research center.
New research suggests that infants who undergo surgical procedures requiring general anesthesia in their first two years of life may be at increased risk of developing attention deficit hyperactivity disorder (ADHD) as they grow older.
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
› Verified 8 days ago
Mini Sra, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Rafat H Ansari, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-234-5123 Fax: 574-282-2813 | |
Dr. Elizabeth Marie Lauber, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Margaret Ann Quate-operacz, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3665 Park Pl W, Suite 300, Mishawaka, IN 46545 Phone: 574-607-4724 Fax: 574-607-4725 | |
Dr. Sayuri Cheruvu, M.B.,B.S Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-237-1328 Fax: 574-237-1348 | |
Anandkumar M Koyani, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 303 S Main St, Suite 109, Mishawaka, IN 46544 Phone: 574-256-0235 Fax: 574-256-0236 | |
Dr. Yufeng Kevin Wu, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Ste 200, Mishawaka, IN 46545 Phone: 574-204-7252 Fax: 574-968-0468 |